This article has an addendum: No external funding was obtained for this article.
Original article: Oncotarget. 2023; 14:153–172. 153-172. https://doi.org/10.18632/oncotarget.28367
. 2023 Aug 7;14:748. doi: 10.18632/oncotarget.28485
Addendum: What is hemoglobin, albumin, lymphocyte, platelet (HALP) score? A comprehensive literature review of HALP’s prognostic ability in different cancer types
Christian Mark Farag
1,✉, Ryan Antar
1, Sinan Akosman
1, Matthew Ng
2, Michael J Whalen
1
Christian Mark Farag
1Department of Urology, George Washington University School of Medicine, Washington, DC 20052, USA
Find articles by Christian Mark Farag
Ryan Antar
1Department of Urology, George Washington University School of Medicine, Washington, DC 20052, USA
Find articles by Ryan Antar
Sinan Akosman
1Department of Urology, George Washington University School of Medicine, Washington, DC 20052, USA
Find articles by Sinan Akosman
Matthew Ng
2Department of Surgery, George Washington University School of Medicine, Washington, DC 20052, USA
Find articles by Matthew Ng
Michael J Whalen
1Department of Urology, George Washington University School of Medicine, Washington, DC 20052, USA
Find articles by Michael J Whalen
1Department of Urology, George Washington University School of Medicine, Washington, DC 20052, USA
2Department of Surgery, George Washington University School of Medicine, Washington, DC 20052, USA
✉
Correspondence to: Christian Mark Farag, email : cmfarag@gwu.edu
Collection date 2023.
Copyright: © 2023 Farag et al.
This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
PMCID: PMC10408685 PMID: 37552218